Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v9-FR | Version v5-FR | |
---|---|---|
Language | French | French |
Date Updated | 2022-09-16 | 2022-08-18 |
Drug Identification Number | 02237925 | 02237925 |
Brand name | AVAPRO | AVAPRO |
Common or Proper name | AVAPRO 300 mg | AVAPRO 300 mg |
Company Name | SANOFI-AVENTIS CANADA INC | SANOFI-AVENTIS CANADA INC |
Ingredients | IRBESARTAN | IRBESARTAN |
Strength(s) | 300MG | 300MG |
Dosage form(s) | TABLET | TABLET |
Route of administration | ORAL ORAL | ORAL ORAL |
Packaging size | HDPE bottles of 90 tablets | HDPE bottles of 90 tablets |
ATC code | C09CA | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
Anticipated start date | 2022-08-12 | 2022-08-12 |
Actual start date | 2022-08-27 | |
Estimated end date | 2022-09-16 | 2022-09-16 |
Actual end date | 2022-09-16 | |
Shortage status | Actual shortage | Actual shortage |
Tier 3 Status | No | No |
Company comments | Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. | Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
Health Canada comments |